These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 213610

  • 21. Role of tumor antigen in vaccine protection in Marek's disease.
    Sharma JM.
    Adv Exp Med Biol; 1977; 88():345-53. PubMed ID: 920519
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Kinetic analysis of T cells and antibody production in chickens infected with Marek's disease virus.
    Yamamoto H, Hattori M, Ohashi K, Sugimoto C, Onuma M.
    J Vet Med Sci; 1995 Oct; 57(5):945-6. PubMed ID: 8593309
    [Abstract] [Full Text] [Related]

  • 25. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF, Liu X, Witter RL.
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.
    Schat KA, Murthy KK.
    J Virol; 1980 Apr; 34(1):130-5. PubMed ID: 6966335
    [Abstract] [Full Text] [Related]

  • 29. Influence of thymic hormone on cell-mediated and humoral immune responses in Marek's disease.
    Quere P, Dambrine G, Bach MA.
    Vet Microbiol; 1989 Jan; 19(1):53-64. PubMed ID: 2538023
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
    Shaikh SA, Katneni UK, Dong H, Gaddamanugu S, Tavlarides-Hontz P, Jarosinski KW, Osterrieder N, Parcells MS.
    Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
    [Abstract] [Full Text] [Related]

  • 35. [Study of the vaccinating properties of 2 variants of Marek's disease virus].
    Iakovleva LS, Merekalova ZI, Pavlovskaia AI, Plakhov IV, Mazurenko NP.
    Vopr Virusol; 1977 Jun; (4):493-6. PubMed ID: 200016
    [Abstract] [Full Text] [Related]

  • 36. A monoclonal antibody reactive with Marek's disease tumor-associated surface antigen.
    Lee LF, Liu X, Sharma JM, Nazerian K, Bacon LD.
    J Immunol; 1983 Feb; 130(2):1007-11. PubMed ID: 6294177
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus.
    Lesnik F, Ross LJ.
    Int J Cancer; 1975 Jul 15; 16(1):153-63. PubMed ID: 170213
    [Abstract] [Full Text] [Related]

  • 39. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA.
    Cancer Surv; 1987 Jul 15; 6(1):1-37. PubMed ID: 2825984
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.